Trial intelligence / Profile preview

Epacadostat ± pembrolizumab with platinum-based chemotherapy in solid tumors

jRCT2080223368Phase 1Completed

Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of epacadostat in Nonhematologic neoplasms and non-small cell lung cancer (NSCLC) (5 arms). Started Nov 2016; status: completed.

02

Drugs

epacadostat
03

Conditions

Nonhematologic neoplasmsnon-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on jRCT2080223368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call